From: Systemic Immuno-metabolic alterations in chronic obstructive pulmonary disease (COPD)
 |  | HNS | HS | TS-COPD |
---|---|---|---|---|
Glucose OCR | ATP Production (%) | 61.3 (56.5–66.2) | 50.7 (48.6–59.6)* | 54.8 (48.8–57.3)** |
Max Resp. Capacity (%) | 91.9 (73.8–109.5) | 80.2 (51.6–93.8) | 72.1 (59.0–75.7)* | |
Spare Resp. Capacity (%) | 87.5 (61.6–105.4) | 57.1 (42.7–69.0)** | 68.0 (57.8–77.3)* | |
Glucose ECAR | Glycolytic Capacity (%) | 315.6 (278.7–358.1) | 194 (170–267.8) | 198.2 (144.4–219.1) * |
Glycolytic Reserve (%) | 92.4 (65.8–102.6) | 84.3 (72.2–110.6) | 57.8 (49.7–64.5)*,## | |
Non-Glycolytic Acidification (%) | 73 (63.4–80.3) | 74.5 (65.7–92) | 94.4 (83.9–99.9)** | |
Palmitate OCR | ATP Production (%) | 53.5 (47.9–72.4) | 62.5 (52.7–75.9) | 37.7 (31.4–45.8)***, ## |
Max Resp. Capacity (%) | 101.6 (94.3–118.9) | 104.2 (98.3–130.7) | 83.1 (56.3–86.5)**, ## | |
Spare Resp. Capacity (%) | 66.7 (47.6–81.1) | 65.3 (61.5–95.6) | 38.5 (32.4–57.1)*, # | |
Non-fatty acid Mitochondrial Resp. (%) | 30.8 (19.5–42.3) | 38.6 (30.6–49.5) | 37.4 (25.6–54.8) |